Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BRT Biotechnologies
Claremont, California, United Stateslinkedin.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
BRT Biotechnologies provides a proprietary platform for ultra-high-throughput synthesis of large and diverse small molecule and macrocycle libraries, enabling rapid identification of promising drug leads. The company focuses on early-stage drug discovery, particularly targeting previously 'undruggable' targets using activity-based screening methods[1][2][3].
- Modalities
- Small moleculesMacrocycles
- Industry
- Drug Discovery Services
Beyond the preview
Go deeper on BRT Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BRT Biotechnologies.